Amin Pharmaceutical Company (DAMIN) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DAMIN
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/09/30 | To 1403/09/30 | To 1402/09/30 | To 1401/09/30 | To 1400/09/30 |
|---|---|---|---|---|---|---|
| Operating revenue | 17,740,371 | 8,984,751 | 11,051,708 | 10,268,335 | 7,217,391 | 3,840,388 |
| Cost of operating revenue | -9,817,484 | -5,249,858 | -6,720,852 | -5,579,859 | -4,257,619 | -2,196,653 |
| Gross profit (loss) | 7,922,887 | 3,734,893 | 4,330,856 | 4,688,476 | 2,959,772 | 1,643,735 |
| Selling, general and administrative expenses | -1,430,686 | -673,189 | -673,697 | -404,910 | -283,077 | -185,711 |
| Other income | 80,609 | 1,221 | 0 | 353 | 0 | 374 |
| Other expenses | -16,638 | -58,469 | -7,596 | -21,671 | -496 | -1,342 |
| Operating profit (loss) | 6,556,172 | 3,004,456 | 3,649,563 | 4,262,248 | 2,676,199 | 1,457,056 |
| Finance costs | -2,341,206 | -2,156,106 | -1,775,954 | -1,187,913 | -746,807 | -448,005 |
| Other non-operating income and expenses | 160,469 | 209,626 | 25,092 | 571,542 | 48,495 | 39,377 |
| Profit (loss) from continuing operations before tax | 4,375,435 | 1,057,976 | 1,898,701 | 3,645,877 | 1,977,887 | 1,048,428 |
| Current year tax | -984,472 | -229,342 | -391,869 | -749,557 | -406,658 | -212,483 |
| Net profit (loss) from continuing operations | 3,390,963 | 828,634 | 1,506,832 | 2,896,320 | 1,571,229 | 835,945 |
| Net profit (loss) | 3,390,963 | 828,634 | 1,506,832 | 2,896,320 | 1,571,229 | 835,945 |
| Basic earnings (loss) per share | 371 rials | 91 rials | 274 rials | 527 rials | 286 rials | 213 rials |
| Net earnings (loss) per share, rials | 372 rials | 91 rials | 274 rials | 527 rials | 286 rials | 214 rials |
| Capital | 9,130,000 | 9,130,000 | 5,500,000 | 5,500,000 | 5,500,000 | 3,920,000 |
Reporting periods
89 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.